Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
12th Nov 201811:12 amRNSNet Asset Value(s)
2nd Nov 20189:52 amRNSNet Asset Value(s)
29th Oct 20181:58 pmRNSNet Asset Value(s)
23rd Oct 20184:03 pmRNSTransaction in Own Shares
22nd Oct 20183:25 pmRNSNet Asset Value(s)
15th Oct 201812:26 pmRNSNet Asset Value(s)
11th Oct 201811:34 amRNSTransaction in Own Shares
10th Oct 201811:42 amRNSTransaction in Own Shares
9th Oct 20181:26 pmRNSIssue of Equity
8th Oct 20182:48 pmRNSNet Asset Value(s)
8th Oct 201811:22 amRNSTransaction in Own Shares
2nd Oct 20183:10 pmRNSNet Asset Value(s)
2nd Oct 20188:38 amRNSHalf-year Report
2nd Oct 20188:34 amRNSDividend Declaration
1st Oct 20184:28 pmRNSTransaction in Own Shares
1st Oct 20189:16 amRNSTotal Voting Rights
21st Sep 20183:16 pmRNSNet Asset Value(s)
17th Sep 20184:21 pmRNSTransaction in Own Shares
14th Sep 20184:12 pmRNSNet Asset Value(s)
13th Sep 20182:58 pmRNSTransaction in Own Shares - Replacement
13th Sep 20181:20 pmRNSIssue of Equity - Replacement
12th Sep 20183:04 pmRNSTransaction in Own Shares
11th Sep 20185:21 pmRNSIssue of Equity
10th Sep 20188:44 amRNSNet Asset Value(s)
4th Sep 20182:35 pmRNSNet Asset Value(s)
3rd Sep 20184:48 pmRNSHolding(s) in Company
3rd Sep 20189:20 amRNSTotal Voting Rights
31st Aug 20183:28 pmRNSTransaction in Own Shares
28th Aug 20182:57 pmRNSNet Asset Value(s)
20th Aug 20188:28 amRNSNet Asset Value(s)
14th Aug 201812:10 pmRNSIssue of Equity - replacement
14th Aug 201810:04 amRNSDirector/PDMR Shareholding
13th Aug 20185:31 pmRNSIssue of Equity
10th Aug 20185:04 pmRNSNet Asset Value(s)
10th Aug 20181:11 pmRNSTransaction in Own Shares - replacement
3rd Aug 201810:57 amRNSTransaction in Own Shares
2nd Aug 20181:31 pmRNSNet Asset Value(s)
1st Aug 20188:34 amRNSTotal Voting Rights
30th Jul 20189:01 amRNSDirector/PDMR Shareholding
27th Jul 20184:05 pmRNSIssue of Equity
27th Jul 201812:56 pmRNSNet Asset Value(s)
26th Jul 20185:01 pmRNSHolding(s) in Company
23rd Jul 20184:48 pmRNSNet Asset Value(s)
20th Jul 20183:32 pmRNSTransaction in Own Shares
17th Jul 201810:47 amRNSTransaction in Own Shares
16th Jul 201810:35 amRNSNet Asset Value(s)
11th Jul 20184:11 pmRNSDirector Declaration
11th Jul 20182:48 pmRNSTransaction in Own Shares
9th Jul 20183:43 pmRNSNet Asset Value(s)
3rd Jul 201812:32 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.